Here are four points:
1. The proceeds will push forth the company’s DTRAX cervical fusion products, which aid patients with cervical degenerative disc disease.
2. Stanmore Medical Investments, Aphelion Capital and other private investors participated in the new financing.
3. Providence named Jason Hoffman to vice president of global sales.
4. Equipped with 20 years of sales and marketing experience in medical device and life sciences industries, Mr. Hoffman previously worked for ArjoHuntleigh and Kinetic Concepts.
“Our focus is on differentiated, tissue-sparing devices and instruments that are designed to improve clinical outcomes, minimize complications, increase procedural efficiency and reduce recovery times,” said Jeff Smith, CEO of Providence.
More articles on devices:
1st surgeries with the Conventus PH Cage in the US & Europe are complete — 5 observations
Mainstay Medical receives new patent for ReActiv8 system: 4 things to know
ApiFix to open scoliosis treatment centers in Europe: 4 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
